EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The selective serotonin reuptake inhibitors, sertraline and paroxetine, improve islet beta‐cell mass and function in vitro

Klaudia Toczyska iD, Naila Haq iD, Zekun Lyu iD, Gavin Bewick iD, Min Zhao, Hannah Rosa iD, Jessica Starikova, Bo Liu iD, Shanta Jean Persaud iD

Diabetes, Obesity and Metabolism · 2024

DOI: 10.1111/dom.15701 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Klaudia Toczyska und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences & Medicine, King's College London, Lon…. Hauptthemen laut MEDLINE: Paroxetine, Sertraline, Selective Serotonin Reuptake Inhibitors, Insulin-Secreting Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To investigate the effects of the selective serotonin reuptake inhibitors (SSRIs) sertraline and paroxetine at therapeutically relevant concentrations on beta‐cell mass and function.

Methods

Viability was quantified in mouse insulinoma (MIN6) beta cells and mouse islets after 48‐h exposure to sertraline (1–10 μM) or paroxetine (0.01–1 μM) using the Trypan blue exclusion test. The effects of therapeutic concentrations of these SSRIs on insulin secretion were determined by static incubation and perifusion experiments, while islet apoptosis was investigated by Caspase‐Glo 3/7 assay, TUNEL staining and quantitative PCR analysis. Finally, proliferation of MIN6 and mouse islet beta cells was assessed by bromodeoxyuridine (BrdU) enzyme‐linked immunosorbent assay and immunofluorescence.

Results

Sertraline (0.1–1 μM) and paroxetine (0.01–0.1 μM) were well tolerated by MIN6 beta cells and islets, whereas 10 μM sertraline and 1 μM paroxetine were cytotoxic. Exposure to 1 μM sertraline and 0.1 μM paroxetine significantly potentiated glucose‐stimulated insulin secretion from mouse and human islets. Moreover, they showed protective effects against cytokine‐ and palmitate‐induced apoptosis of islets, they downregulated cytokine‐induced Stat1 and Traf1 mRNA expression, and they significantly increased proliferation of mouse beta cells.

Conclusions

Our data demonstrate that sertraline and paroxetine act directly on beta cells to enhance glucose‐stimulated insulin secretion and stimulate beta‐cell mass expansion by increasing proliferation and decreasing apoptosis. These drugs are therefore likely to be appropriate for treating depression in people with type 2 diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ParoxetineSertralineSelective Serotonin Reuptake InhibitorsInsulin-Secreting CellsInsulin SecretionApoptosisCell ProliferationAnimalsMiceHumansInsulinCell SurvivalMaleIslets of Langerhans

Stichwörter der Autor:innen

beta‐cell functiondrug mechanisminsulin secretionisletstype 2 diabetes

Substanzen

ParoxetineSertralineSelective Serotonin Reuptake InhibitorsInsulin

Autor:innen und Institutionen

  • Department of Diabetes, School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.

ORCID-Profile: Klaudia Toczyska, Naila Haq, Zekun Lyu, Gavin Bewick, Hannah Rosa, Bo Liu, Shanta Jean Persaud

Förderung

  • Wellcome Trust
  • Medical Research Council

Zitieren

APA

Toczyska, K., Haq, N., Lyu, Z., Bewick, G., Zhao, M., Rosa, H., Starikova, J., Liu, B., & Persaud, S. J. (2024). The selective serotonin reuptake inhibitors, sertraline and paroxetine, improve islet beta‐cell mass and function in vitro. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15701

Vancouver

Toczyska K, Haq N, Lyu Z, Bewick G, Zhao M, Rosa H, et al. The selective serotonin reuptake inhibitors, sertraline and paroxetine, improve islet beta‐cell mass and function in vitro. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15701

BibTeX
@article{Toczyska2024,
  author = {Toczyska, Klaudia and Haq, Naila and Lyu, Zekun and Bewick, Gavin and Zhao, Min and Rosa, Hannah and Starikova, Jessica and Liu, Bo and Persaud, Shanta Jean},
  title = {The selective serotonin reuptake inhibitors, sertraline and paroxetine, improve islet beta‐cell mass and function in vitro},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  doi = {10.1111/dom.15701}
}
Kostenlos starten →